El 76 %
de los inversores minoristas pierde dinero cuando opera CFDs con este proveedor.
Invertir conlleva riesgos y no es adecuado para todos los inversores. Los CFDs son instrumentos complejos y conllevan un alto riesgo de perder dinero rápidamente debido al apalancamiento.
El 76 %
de inversores minoristas pierde dinero al operar CFDs con este proveedor.
Debes considerar si entiendes cómo funcionan los CFDs y si puedes permitirte asumir el alto riesgo de perder tu dinero.
El 76 %
de los inversores minoristas pierde dinero cuando opera CFDs con este proveedor.
Invertir conlleva riesgos y no es adecuado para todos los inversores. Los CFDs son instrumentos complejos y conllevan un alto riesgo de perder dinero rápidamente debido al apalancamiento.
El 76 %
de inversores minoristas pierde dinero al operar CFDs con este proveedor.
Debes considerar si entiendes cómo funcionan los CFDs y si puedes permitirte asumir el alto riesgo de perder tu dinero.
Neogen Corp
Cerrado
SectorSanidad
4.71 -1.67
Resumen
Variación precio
24h
Mínimo
4.59
Máximo
4.81
Ingresos | 445M -11M |
|---|---|
Ventas | -10M 221M |
P/B Media del Sector | 657.5 50.291 |
BPA | 0.1 |
Margen de beneficios | -4.958 |
Empleados | 2,917 |
EBITDA | 495M 37M |
Recomendaciones | Comprar |
|---|---|
Estimación a 12 Meses | +84.8% upside |
Próximas Ganancias | 29 jul 2025 |
|---|
Capitalización Mercado | -1.1B 1.1B |
|---|---|
Apertura anterior | 6.38 |
Cierre anterior | 4.71 |
Noticias sobre sentimiento de mercado
By Acuity
50%
50%
154 / 380 Clasificación en Healthcare
Puntuación técnica
By Trading Central
Confianza
Strong Bullish Evidence
Neogen Corp Gráfico
Resultados pasados no son un indicador fiable de resultados futuros.
Noticias Relacionadas
Comparación entre iguales
Cambio de precio
Neogen Corp previsión
Precio Objetivo
By TipRanks
84.8% repunte
Estimación a 12 Meses
Media 9 USD 84.8%
Máximo 13 USD
Mínimo 5 USD
De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Neogen Corp Dist en los últimos 3 meses.
Sentimiento
By Acuity
154 / 380 Clasificación en Sanidad
Noticias sobre sentimiento de mercado
Neutral
Volatilidad
Por debajo de la media
Volumen de Noticias (RCV)
Por encima de la media
Finanzas
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$
Acerca de Neogen Corp
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared food products and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. The company was incorporated in 1981 and is headquartered in Lansing, Michigan.
